Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Conduit Pharmaceuticals Inc (CDT)

Conduit Pharmaceuticals Inc (CDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Conduit Pharmaceuticals Inc 4581 Tamiami Trail North Suite 200 Naples FL 34103 USA

www.conduitpharma.com Employees: 6 P: 646-491-9132

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Conduit Pharmaceuticals Limited is a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development. Conduit Pharmaceuticals Limited, formerly known as Murphy Canyon Acquisition Corp., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 4,132
Enterprise Value, $K 3,582
Shares Outstanding, K 6,663
Annual Sales, $ 0 K
Annual Net Income, $ -17,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,410 K
EBIT, $ -15,420 K
EBITDA, $ -12,370 K
60-Month Beta 2.37
% of Insider Shareholders 30.93%
% of Institutional Shareholders 3.29%
Float, K 4,602
% Float 69.07%
Short Volume Ratio 0.46

Growth:

1-Year Return -99.79%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -20.33 on 03/28/25
Next Earnings Date 05/13/25 [--]
Earnings Per Share ttm -39.33
EPS Growth vs. Prev Qtr -190.43%
EPS Growth vs. Prev Year 345.62%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 01/27/25

CDT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -462.15%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -4.92
Interest Coverage -10.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar